Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Ainos Inc. currently has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are split among 3 distinct examiners, providing a diverse set of reviews for the company's medical innovations. The portfolio is spread across 2 distinct art units, which suggests that the 3 pending office actions involve different specialized sub-fields. This distribution requires the company to navigate the unique examination cultures of 2 distinct art units simultaneously.
KIM, SAMUEL CHONG is the busiest examiner, responsible for 1 busiest examiner pending action. With 3 pending office actions and 3 distinct examiners, the workload is perfectly distributed. This lack of concentration prevents any single examiner from having a disproportionate influence on the portfolio's outcomes. However, the involvement of 2 distinct art units means that the prosecution team must be prepared for different technical benchmarks. Successfully managing these 3 pending office actions will require a flexible approach that addresses the specific concerns of the 3 distinct examiners while maintaining overall portfolio consistency.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, SAMUEL CHONG | 1 | 48.7% | +70.4% |
| TRUONG, QUANGLONG N | 1 | 78.8% | +23.6% |
| ABBAS, SYED JARAR | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18140535 | METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION | ABBAS, SYED JARAR | 5d overdue |
| 18771339 | Portable kit and device for detecting or identifying diseases or disorders in a human subject by collecting biological sample from the human subject | KIM, SAMUEL CHONG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18771339 | Portable kit and device for detecting or identifying diseases or disorders in a human subject by collecting biological sample from the human subject | KIM, SAMUEL CHONG | — |
| 18733102 | PROCESS FOR MANUFACTURING ORALLY DISINTEGRATING TABLET COMPRISING CYTOKINE | TRUONG, QUANGLONG N | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18771339 | Portable kit and device for detecting or identifying diseases or disorders in a human subject by collecting biological sample from the human subject | KIM, SAMUEL CHONG | 3791 | §103§112 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18733102 | PROCESS FOR MANUFACTURING ORALLY DISINTEGRATING TABLET COMPRISING CYTOKINE | TRUONG, QUANGLONG N | — | §103 | Non-Final OA | — | Pending | Jun 04, 2024 |
| 18140535 | METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION | ABBAS, SYED JARAR | 1674 | §102 | Final Rejection | 5d overdue | Pending | Apr 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial